Editorial [Pharmacology and Therapeutic Activity of Purinergic Drugs for Disorders of the Nervous System]

E-ISSN： 1996-3181|11|6|649-651

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.6, 2012-09, pp. : 649-651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 12, Iss. 3, 2012-01 ,pp. : 153-157

Bentham Science Publishers

Access to resources Recommend Favorite

Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity

Current Medicinal Chemistry, Vol. 18, Iss. 5, 2011-02 ,pp. : 638-666

Bentham Science Publishers

Access to resources Recommend Favorite

ABCA2 as a therapeutic target in cancer and nervous system disorders

By Mack Jody T Brown Carol B Tew Kenneth D

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. : 491-504

Informa Healthcare

Access to resources Recommend Favorite

P2Y Receptors in the Mammalian Nervous System: Pharmacology, Ligands and Therapeutic Potential

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 6, 2012-09 ,pp. : 722-738

Bentham Science Publishers

Access to resources Recommend Favorite

P 2 Purinergic Receptors for Diadenosine Polyphosphates in the Nervous System

By Pintor J. Miras-Portugal M.T.

General Pharmacology, Vol. 26, Iss. 2, 1995-03 ,pp. : 229-235

Elsevier

Access to resources Recommend Favorite